Early Release
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 30, Number 6—June 2024
Perspective
- Decolonization and Pathogen Reduction to Prevent Antimicrobial Resistance and Healthcare-Associated Infections
Synopses
- Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France
- An Electronic Health Record–Based Algorithm for Respiratory Virus–like Illness
- Severe Human Parainfluenza Virus Community- and Healthcare-Acquired Pneumonia in Adults at Tertiary Hospital in Seoul, South Korea, 2010–2019
Research
- SARS-CoV-2 Disease Severity in Children during Pre-Delta, Delta, and Omicron Periods, Colorado
- Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Pneumococcal Disease in Follow-Up Study, Denmark
- Chest Radiograph Screening for Detection of Subclinical Tuberculosis in Asymptomatic Household Contacts, Peru
- Outbreak of Highly Pathogenic Avian Influenza Virus H5N1 in Seals in the St. Lawrence Estuary, Quebec, Canada
- Carbapenem-Resistant and Extended-Spectrum β-Lactamase–Producing Enterobacterales Cases among Children, United States, 2016–2020
Dispatches
- Antibodies to H5N1 Influenza A Virus in Retrieving Hunting Dogs, Washington State, USA
-
Evolution and Antigenic Differentiation of Avian Influenza A(H7N9) Virus, China
We characterized the evolution and molecular characteristics of avian influenza A(H7N9) viruses isolated in China during 2021–2023. We systematically analyzed the 10-year evolution of the hemagglutinin gene to determine the evolutionary branch. Our results showed recent antigenic drift, providing crucial clues for updating the H7N9 vaccine and disease prevention and control.
- Burkholderia semiarida as Cause of Recurrent Pulmonary Infection in Immunocompetent Patient, China
- SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020–2023
- Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence in Persons 0–101 Years of Age, Japan, 2023
- Zoonotic Ancylostoma ceylanicum Infection in Coyotes from the Guanacaste Conservation Area, Costa Rica, 2021
- Detection of Encephalitozoon cuniculi in Cerebrospinal Fluid from Immunocompetent Patients, Czech Republic
- Emergence of Group B Streptococcus Disease in Pigs and Porcupines, Italy
- Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
-
Autochthonous Plasmodium vivax Infections, Florida, USA, 2023
During May–July 2023, a cluster of 7 patients at local hospitals in Florida, USA, received a diagnosis of Plasmodium vivax malaria. Whole-genome sequencing of the organism from 4 patients and phylogenetic analysis with worldwide representative P. vivax genomes indicated probable single parasite introduction from Central/South America.
Research Letters
-
Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine
Because novel SARS-CoV-2 variants continue to emerge, immunogenicity of XBB.1.5 monovalent vaccines against live clinical isolates needs to be evaluated. We report boosting of IgG (2.1×), IgA (1.5×), and total IgG/A/M (1.7×) targeting the spike receptor-binding domain and neutralizing titers against WA1 (2.2×), XBB.1.5 (7.4×), EG.5.1 (10.5×), and JN.1 (4.7×) variants.
-
Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan
Using the GISAID EpiCoV database, we identified 256 COVID-19 patients in Japan during March 31–December 31, 2023, who had mutations in the SARS-CoV-2 nonstructural protein 5 conferring ensitrelvir resistance. Ongoing genomic surveillance is required to monitor emergence of SARS-CoV-2 mutations that are resistant to anticoronaviral drugs.
- Novel Avian Influenza A(H5N6) in Wild Birds, South Korea, 2023
Volume 30, Number 7—July 2024
Dispatch
- Borrelia miyamotoi-associated Acute Meningoencephalitis, Minnesota, United States
Research Letter
- Pasteurella bettyae Infections in Men Who Have Sex With Men, France